TT Electronics to Spotlight its Radwave Technologies Collaboration at MD&M Minneapolis with Demo of New Electromagnetic Platform for Surgical Navigation

TT will also feature its core specialties for the medical device industry, including high reliability sensor, power and connectivity technologies, and global manufacturing

TT Electronics, a global provider of engineered technologies for performance-critical applications, will be exhibiting at MD&M Minneapolis 2021, November 3-4 in Minneapolis, Minnesota.

TT will showcase its collaboration with Radwave Technologies, bringing to market an innovative electromagnetic (EM) tracking platform for surgical navigation. The platform is customizable to enable accurate tracking of a broad spectrum of minimally invasive diagnostic and therapeutic devices during surgical procedures with no clear line of sight.

This advanced technology offers solutions for medical device innovators that are seeking to add new or improved EM capabilities to their medical products. Demonstrations will be available at TT’s booth #1608. TT will also highlight its core specialties, reflecting the company’s strategic focus on sustainability and developing technology solutions that enable a cleaner, smarter, healthier future:

●        Medical grade power supplies and solutions – reliable power conversion and management to drive product performance while maintaining efficiency and safety; these include miniaturized coils, transformers, and inductors uniquely developed for implantable devices and surgical navigation in clinical care, therapy and well-being, and home healthcare environments

●        Smart sensors and passive components – designed to capture data, inform decisions, support data analytics, and enable artificial intelligence; these include non-contact, Hall effect sensors, infrared optical switches and arrays for detection of objects or fluids, and fixed and variable resistors for current sensing, power management, and signal conditioning

●        Connectivity Solutions – built to connect, sense, track, and monitor, including wearable IoT devices, and wireless devices communicating over GSM and LTE Cat M1/NB-IoT for use in fast-paced healthcare and pharmaceutical environments

●        End-to-end, low-volume, high-mix global manufacturing in FDA-registered facilities – offerings span engineering, test development, system integration and fulfilment services for imaging/nuclear and monitoring equipment, diagnostic instruments, and cardiology and electrosurgical devices

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”